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Specific chromatin marks keep master regulators of
differentiation silent yet poised for activation by
extracellular signals. We report that nodal TGF-b
signals use the poised histone mark H3K9me3 to
trigger differentiation of mammalian embryonic
stem cells. Nodal receptors induce the formation of
companion Smad4-Smad2/3 and TRIM33-Smad2/3
complexes. The PHD-Bromo cassette of TRIM33
facilitates binding of TRIM33-Smad2/3 to H3K9me3
and H3K18ac on the promoters of mesendoderm
regulators Gsc and Mixl1. The crystal structure of
this cassette, bound to histone H3 peptides, illus-
trates that PHD recognizes K9me3, and Bromo binds
an adjacent K18ac. The interaction between TRIM33-
Smad2/3 and H3K9me3 displaces the chromatin-
compacting factor HP1g, making nodal response
elements accessible to Smad4-Smad2/3 for Pol II
recruitment. In turn, Smad4 increases K18 acetyla-
tion to augment TRIM33-Smad2/3 binding. Thus,
nodal effectors use the H3K9me3 mark as a platform
to switch master regulators of stem cell differentia-
tion from the poised to the active state.
INTRODUCTION
The transforming growth factor b (TGF-b) family playsmajor roles
in embryonic development, tissue homeostasis, adult immunity,
and wound repair (Flavell et al., 2010; Massague´, 2008; Shen,
2007; Wu and Hill, 2009). The family members nodal and bone
morphogenetic proteins (BMPs) specify the differentiation of
primitive embryonic cells into the three layers of the embryo
and their derivative lineages. In both embryonic and
differentiated cells, TGF-b family members additionally control
a plethora of homeostatic functions, including cell proliferation,Cmovement, adhesion, and intercellular communication. Smad
transcription factors mediate a majority of these effects.
Binding of TGF-b ligands to receptor serine/threonine kinases
causes the phosphorylation and activation of Smads 2 and 3 in
the case of TGF-b, nodal, activin, and myostatin, and of
Smads 1, 5, and 8 in the case of BMPs. Activated Smads bind
Smad4, accumulate in the nucleus, and target specific
enhancer elements by interacting with other DNA-binding
proteins. On the DNA, Smad complexes recruit histone acetyl-
transferases, the Mediator, and SWI/SNF chromatin remodeling
complex for transcriptional stimulation of target genes, or
histone deacetylases for transcriptional inhibition (Massague´
et al., 2005).
Genes that control homeostasis generally have an active
chromatin state and respond to TGF-b signals with an increase
or a decrease in transcriptional output. In contrast, master
regulators of differentiation are transcriptionally repressed yet
poised for acute activation by specific developmental signals
(Young, 2011). In embryonic stem cells (ESCs), this poised
state results from the action of Oct4, Sox2, and Nanog, which
are core transcriptional enforcers of pluripotency. These factors
stimulate polycomb group (PcG) proteins and SetDB1 to
mediate histone methylation. SetDB1 catalyzes trimethylation
of Lys9 on histone H3 (H3K9me3). H3K9me3 is present in
the promoter region of master regulators and is also a
hallmark of heterochromatin (Mikkelsen et al., 2007). It binds
heterochromatin protein 1 (HP1), which mediates chromatin
compaction (Ruthenburg et al., 2007). Poised genes are
transcriptionally quiescent but may harbor paused RNA
polymerase II (Pol II) at the start site, ready to proceed with
transcription elongation in response to developmental cues
(Young, 2011).
The nature of the poised state implies that activation of master
regulator genes by the TGF-b/SMAD pathway has specific
requirements that may not apply to the regulation of cell homeo-
stasis genes. To investigate how developmental signals activate
master regulators, we focused on the role of nodal in ESC differ-
entiation. An early effect of nodal during embryogenesis is theell 147, 1511–1524, December 23, 2011 ª2011 Elsevier Inc. 1511
activation of goosecoid (Gsc) andMix-like homeodomain protein
1 (Mixl1) (Blum et al., 1992; Chen et al., 1997; Hart et al., 2002).
Gsc belongs to the bicoid subfamily of paired homeobox
transcription factors and Mixl1 to the Mix/Bix subfamily. Gsc
and Mixl1 are expressed in the primitive streak and function in
gastrulation, axial mesendoderm morphogenesis, and
endoderm formation. Activation of Gsc and Mixl1 involves
a complex of Smad2/3, Smad4, and the forkhead box family
member FoxH1 (Chen et al., 1997; Labbe´ et al., 1998). This
complex binds to sequences known as ‘‘activin response
elements’’ (AREs) in the proximal promoters of Gsc and Mixl1
for transcription activation.
In our analysis of how Smad proteins gain access to AREs that
are embedded in poised chromatin, several clues led us to focus
on tripartite motif (TRIM) 33, a Smad-binding protein with contra-
dictory proposed roles (Dupont et al., 2005; He et al., 2006).
Trim33-deficient mouse embryos die early, lacking mesoderm,
and with a phenotype that is suggestive of altered nodal
signaling (Morsut et al., 2010). The conditional knockout (KO)
of Trim33 in premalignant pancreatic progenitors phenocopies
that of Smad4 and suggests that TRIM33 and Smad4
converge on pancreatic tumor suppression (Bardeesy et al.,
2006; Vincent et al., 2009). In human cells, TRIM33 is
dispensable for TGF-b activation of homeostatic gene
responses but implicated in TGF-b dependent erythroid
differentiation (He et al., 2006). In zebrafish, TRIM33 is required
for transcriptional elongation of erythroid differentiation genes
(Bai et al., 2010). Notably, TRIM33 has structural features of
a histone-binding protein. Here, we report an essential role for
TRIM33 in the activation of Gsc and Mixl1 by nodal signals,
and delineate how Smads gain access to poised promoters of
master regulators under the command of nodal TGF-b signals.
RESULTS
TRIM33 Is Engaged in the Nodal Smad Pathway
TRIM33 immunostaining was present in the majority of nuclei in
all regions of stage embryonic day (E) 7.5 mouse embryos
(Figure 1A). These regions included the node (Figure 1B) and
primitive streak (Figure 1C), which under the control of nodal,
specify the site of gastrulation, determine bilateral symmetry,
and undergo mesoderm and endoderm differentiation (Shen,
2007). To probe the involvement of TRIM33 in these
processes, we used mouse ESCs (mESCs) derived from the
inner cell mass. Nodal shares receptors with activin, including
the type I receptors ALK4 (ActR-IB) and ALK7, and the type II
receptors ActR-II and ActR-IIB (Reissmann et al., 2001; Yeo
and Whitman, 2001). mESCs express ALK4, ALK7, ActR-II,
and ActR-IIB (see Table S1 available online). We used the
ALK4/7 kinase inhibitor SB431542 to block stimulation by
nodal-like factors in the media (Figure 1D, first lanes). For
receptor activation we used activin A (hereafter, activin)
because this ligand is more readily available from mammalian
sources than is nodal. Activin addition to mESCs induced the
formation of TRIM33-Smad2/3 and Smad4-Smad2/3
complexes, with similar kinetics (t1/2 30 min) (Figure 1D).
TRIM33-immunoprecipitated complexes contained Smad2/3,
but no detectable Smad4 (Figure S1A), and formation of the1512 Cell 147, 1511–1524, December 23, 2011 ª2011 Elsevier Inc.TRIM33-Smad2/3 complex did not require Smad4, as deter-
mined with Smad4 null mESCs (Figure 1E). Conversely,
depletion of TRIM33 by means of shRNA or KO did not inhibit
the formation of the Smad4-Smad2/3 complex (Figures 1F,
S1B, and S1C). Preventing the formation of one complex
enhanced the accumulation of the other (Figures 1F and S1B).
Thus, nodal/activin stimulation in mESCs rapidly induces the
formation of separate TRIM33-Smad2/3 and Smad4-Smad2/3
protein complexes.
TRIM33-Dependent and -Independent Nodal
Gene Responses
When switched to culture conditions that are permissive for
differentiation, mESCs form embryoid bodies (EBs) that can
subsequently differentiate into all three germ layer fates (Murry
and Keller, 2008). EBs recapitulate the effect of nodal on Gsc
and Mixl1 activation and induction of mesoderm and
endoderm differentiation. We shifted ESCs to differentiation-
permissive conditions for 2.5 days and determined the require-
ment of TRIM33, Smad4, and Smad2/3 for the acute induction
of Gsc, Mixl1, and Smad7 in response to added activin
(Figures 1G and 1H). Smad7 is an inhibitory Smad commonly
induced by TGF-b family members for feedback regulation of
the pathway. mESCs that were null for Smad4 (Chu et al.,
2004), or depleted of Smad3 in a Smad2 null background
(Dunn et al., 2005) (Figure S1D), lacked Gsc, Mixl1, and Smad7
responses to added activin or to endogenous (SB431542-
sensitive) nodal-like factors (Figure 1G). Notably, RNAi-
mediated depletion of TRIM33 strongly blunted the induction
of Gsc and Mixl1, but not that of Smad7. Reconstitution of
TRIM33-depleted cells with an shRNA-insensitive TRIM33
vector restored the Gsc and Mixl1 responses (Figure 1G).
Activin also failed to stimulate the expression ofGsc andMixl1
in two independent Trim33 null ESC lines, whereas it stimulated
the expression of the common Smad2/3 target genes Smad7,
Skil (encoding SnoN), and SerpinE1 (encoding plasminogen
activator inhibitor-1, PAI1) in these cells (Figures 1H, S1B, and
S1E). Thus, induction of the master regulators Gsc and Mixl1
requires both TRIM33 and Smad4, whereas induction of the
homeostasis genes requires Smad4, but not TRIM33
(Figure 1I). Lefty1, which encodes a feedback inhibitor of nodal
binding to receptors, showed a complex response profile.
Lefty1 induction by activin was blunted in Trim33 null mESCs
(Figure S1F; data not shown) as well as in Smad4 null mESCs
that were depleted of TRIM33 (Figures S1G and S1H).
Genome-wide transcriptomic analysis showed that of all
the activin gene responses in EBs (>3-fold change; p < 0.05),
a large proportion (333 of 407 responses) requires both Smad4
and TRIM33 (Figure 1J). In contrast most of the TGF-b
responses in human HaCaT keratinocytes and MDA-MB-231
breast carcinoma cells were inhibited by RNAi-mediated
depletion of Smad2/3 and Smad4, but not by depletion
of TRIM33 (Gomis et al., 2006; unpublished data). Depletion of
TRIM33 did not significantly alter the TGF-b response of
SMAD7, SKIL, and SERPINE1 in HaCaT or MDA-MB-231 cells,
as determined by quantitative RT-PCR (qRT-PCR) (Figures
S1K and S1L). TRIM33 depletion did not diminish the response
of luciferase reporter constructs driven by the TGF-b response
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Figure 1. TRIM33 Is Engaged in the Nodal Smad Pathway
(A–C) Distribution of TRIM33 in stage E7.5 mouse embryos. Immunohistochemistry analysis of mouse embryo sections with antibodies against TRIM33. Images
are (A) whole embryo (303 magnification), (B) node region (1503), and (C) primitive streak (1503).
(D) Activin-dependent formation of TRIM33-Smad2/3 and Smad4-Smad2/3 complexes in mESCs. mESC cultures were stimulated with activin (50 ng/ml) for the
indicated time periods or treated with SB431542 (SB) (10 mM) to block autocrine nodal-like signals. Cell lysates were immunoprecipitated (IP) with anti-Smad2/3
antibody, and immune complexes were analyzed by immunoblotting using antibodies against the indicated proteins.
(E) Formation of the TRIM33-Smad2/3 complex in WT and Smad4 null mESCs.
(F) Formation of Smad4-Smad2/3 complex in WT and Trim33-depleted mESCs.
(G) mESCs that were WT, Trim33 depleted, reconstituted with TRIM33, Smad2/3 depleted, or Smad4 null were set for EB formation for 2.5 days and then
incubated for 2 hr with activin, SB, or no additions. RNA was analyzed by qRT-PCR using primers for the indicated genes. Error bars represent the mean ±
standard deviation (SD) of quadruplicates and three independent experiments.
(H) WT or Trim33 null mESCs were treated and analyzed as described in (G).
(I) Schematic representation of TRIM33 and Smad4-dependent nodal/activin gene responses.
(J) Control, Trim33-depleted, and Smad4 null ESCs were set for EB formation for 2.5 days and processed as in (G). Total RNA was subjected to genome-wide
transcriptomic analysis with MOE 430A 2.0 microarray. The Venn diagram shows a summary of TRIM33 and Smad4-dependent and -independent activin
responsive genes (>3-fold change; p < 0.05).
See Figure S1 for additional information about how TRIM33 participates in activin and TGF-b responses.element from SERPINE1 (PAI1) in HaCaT cells (Figure S1M) or
by repeats of the Smad-binding element (SBE) CAGAC in
MDA-MB-231 cells (Figure S1N). TRIM33 depletion actually
increased the activity of these constructs, an effect not
observed with endogenous TGF-b target genes (refer to
Figures S1K and S1L).CMesendodermal Differentiation of ESCs Requires
TRIM33
EB differentiation can be tracked by the expression of specific
markers (summarized in Figure 2A) (Murry and Keller, 2008).
Fgf5 marks the epiblastic primitive ectoderm, and Sox1, nestin,
and Pax6 mark the definitive ectoderm. Endogenous nodalell 147, 1511–1524, December 23, 2011 ª2011 Elsevier Inc. 1513
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Figure 2. TRIM33 Is Required for Mesendodermal Differentiation of Mammalian ESCs
(A) Schematic summary of mESC differentiation in culture (Murry and Keller, 2008).
(B) Trim33 null mESCs were verified by immunoblot analysis using antibody against TRIM33.
(C–F) Expression pattern of three germ layer markers in mESC differentiation. WT and Trim33 null mESCs (two clones each) were set for EB formation for the
indicated lengths of time. Total RNA was analyzed by qRT-PCR using primers for the indicated genes. Error bars represent the mean ± SD of quadruplicates and
two independent experiments.
(G) TRIM33 was depleted in hESCs using lentiviral shRNA vector (refer to Figure S2I). Control and TRIM33 knockdown were set for mesoderm differentiation, and
total RNA was analyzed by qRT-PCR using primers for the indicated genes. Error bars represent the mean ± SD of quadruplicates and two independent
experiments.
(H) Immunofluorescence analysis of mesendoderm markers Foxa2 and T/Brachyury, and ectodermmarker Nestin in WT and Trim33-depleted mouse EBs at the
indicated times.
For additional information related to the role of TRIM33 in ESC differentiation, see Figure S2.drives EBs to mesendoderm differentiation through Gsc, Mixl1,
and brachyury (also known as T), which mark the primitive
streak stage and specify expression of Foxa2. This is followed
by the expression of late mesoderm and endoderm markers
(Figure 2A). In the embryo, nodal expression is first detected in
the inner cell mass of the blastocyst (E4.5) and persists until
the extended primitive streak stage (E7.5) (Collignon et al.,1514 Cell 147, 1511–1524, December 23, 2011 ª2011 Elsevier Inc.1996). In EBs, nodal was expressed up to day 6, and the
expression was not affected by the absence of TRIM33
(Figures 2B and 2C). The nodal coreceptors cripto and cryptic
(Yeo and Whitman, 2001) were sequentially expressed in EBs
up to day 6 (Figure S2A). RNAi-mediated depletion of both
coreceptors (Figure S2B) inhibited the expression of Gsc and
Mixl1 (Figure S2C; data not shown), suggesting that autocrine
nodal drives the expression. Cripto/cryptic-depleted cells
remained responsive to activin (Figure S2D).
Absence of TRIM33 in EBs had little effect on the expression
of Fgf5, but it abolished the expression of Gsc, Mixl1, and
brachyury (Figure 2D) and of the late mesoderm markers
Foxa2, Scl/Tal, and Nkx2.5 (Figure 2E). Notably, TRIM33 was
dispensable for ectoderm differentiation (Figure 2F). Similar
results were obtained by RNAi-mediated depletion of TRIM33
in mESCs of a different genetic background (Figures S1C and
S2E–S2G). Expression of the definitive endoderm marker
Pdx1, which requires a high concentration of activin (Kubo
et al., 2004), was also blunted in TRIM33-depleted EBs
(Figure S2H). Furthermore, TRIM33 depletion in human ESCs
(hESCs) (Figure S2I) markedly inhibited the expression of GSC,
MIXL1, and T/BRACHYURY (Figure 2G) as well as that of
FOXA2 and SOX17 (Figure S2J), which are endoderm markers
in hESCs (Zorn and Wells, 2009). The inhibition of mesoderm
but not ectoderm differentiation in TRIM33-depleted mouse
EBs was confirmed by marker protein immunostaining
(Figure 2H).
TRIM33 Recognizes a Dual Histone Mark Motif
TRIM33 consists of an N-terminal region containing RING,
B box, and coiled-coil domains (TRIM), a middle region that
binds Smad2/3, and a C-terminal region that contains one plant
homeodomain (PHD) adjacent to a Bromo domain (Bromo)
region (He et al., 2006) (Figure 3A). By reconstituting TRIM33-
depleted EBs with either the wild-type (WT) TRIM33 or
a TRIM33(Dphd) construct lacking the PHD finger, we observed
that the PHD finger is essential for the induction of Gsc and
Mixl1 by added activin (Figure 3B) or autocrine nodal
(Figure 3C). TRIM33 with the double mutation C125A and
C128A in the RING domain, which is designed to disrupt
protein ubiquitylation (Dupont et al., 2005), also rescued the
Gsc, Mixl1, and Lefty1 responses in Trim33 null EBs (Figures
S3A and S3B).
PHD and Bromos can bind posttranslationally modified
histones (Taverna et al., 2007). Using recombinant, epitope-
tagged TRIM33 PHD-Bromo cassette and histone N-terminal
peptides, we observed a weak basal binding of TRIM33 to
unmodified histone H3, and a gain in affinity for peptides contain-
ing K9 methylation, particularly trimethylation (Figure 3D).
H3K4me3 and H3K27me3 did not mediate TRIM33 binding
(Figure 3E). Deletion of the PHD finger, deletion of the Bromo,
or alanine mutation of three highly conserved residues in the
PHD finger (Wang et al., 2009), abolished the H3-binding activity
(Figure 3D). Isothermal titration calorimetry (ITC)-binding
measurements confirmed that the TRIM33 PHD prefers to bind
H3 peptide containing unmodified K4 and trimethylated K9
(Figure 3F; Table S2).
We next tested the contribution of histone lysine acetylation to
TRIM33 binding. A histone H3 N-terminal peptide acetylated at
K18 showed enhanced binding to TRIM33 compared to the
unmodified peptide, whereas acetylation at K14 had little effect
(Figure 3G). The combination of K9me3 and K18ac bound to
TRIM33 PHD-Bromo more avidly than any of these marks alone
(Figures 3G and 3H). A histone H3 N-terminal peptide containing
K9me3, K14ac, K18ac, and K23ac bound slightly better toCTRIM33 than did the H3K9me3-K18ac peptide (Figure S3C).
Collectively, these results demonstrate a high affinity of the
TRIM33 PHD-Bromo cassette for histone H3 containing unmod-
ified K4, K9me3, and K18ac (summarized in Figure 3A).
Structural Basis for K9me3-K18ac Recognition
by TRIM33 PHD-Bromo Cassette
Based on previous knowledge (Dhalluin et al., 1999; Lan et al.,
2007; Li et al., 2006; Pen˜a et al., 2006), we hypothesized that
the TRIM33 PHD-Bromo cassette could simultaneously target
unmodified K4 and K9me3 marks using its PHD finger and Kac
marks on the sameH3 tail using its Bromo. To address this issue,
we solved crystal structures of the TRIM33 PHD-Bromo cassette
both in the free state and bound to H3 peptides containing
different modifications (Table S3). The 3.1 A˚ crystal structure of
the TRIM33 PHD-Bromo cassette in the free state was
compared with its TRIM24 counterpart (Figure 4A) (Tsai et al.,
2010). In both structures, the PHD finger adopts the
characteristic cross-braced folding topology stabilized by
a pair of bound Zn ions, whereas the Bromo adopts the charac-
teristic left-handed four-helical bundle topology (Taverna et al.,
2007). The PHD finger and Bromo interact extensively and
utilize similar interfaces in TRIM33 and TRIM24 (Figure 4A).
Notably, there is a 17 amino acid insert within the Bromo of
TRIM33 (Figure S4A), and this is reflected in an a-helical
extension of helix aB in TRIM33 that abuts the binding pocket
of the Bromo (Figure 4A).
In the 2.7 A˚ crystal structure of TRIM33 PHD-Bromo cassette
bound to H3(1–22)K9me3-K14acK18ac peptide (Figure 4B),
a single modified H3 peptide traverses both the PHD finger
and the Bromo. The cassette forms a single functional unit for
potential recognition of multiple marks on a single histone tail.
The H3(1–10)K9me3 segment forms an antiparallel b sheet with
a segment of the TRIM33 PHD finger (Figure 4C). The key
intermolecular contacts are between the positively charged N
terminus and the peptide backbone, multiple hydrogen bonds
between the ammonium group of unmethylated K4 and acidic
residues Asp884, Asp888 and the carbonyl oxygen of Glu887,
and stacking of the trimethyl group of K9me3 over the indole
ring of Trp889. The H3K18ac residue is inserted into the
Bromo-binding pocket, with sequence specificity associated
with recognition of the R17-K18ac step, given that the guanidi-
nium group of R17 forms a hydrogen bond with the side chain
of Glu981 from Bromo (Figure 4D). By contrast the K14ac side
chain is disordered and appears not to be involved in
intermolecular recognition in this complex.
The longer H3(1–28)K9me3-K14acK18acK23ac peptide also
spans a single TRIM33 PHD-Bromo cassette in the 2.8 A˚ crystal
structure of its complex (Figure S4B). Importantly, it is the
K18ac rather than the K23ac side chain that is positioned in
the Bromo-binding pocket, with the side chains of both K14ac
and K23ac being disordered in the complex. By contrast the
shorter H3(1–20)K9me3-K14ac peptide binds two TRIM33
PHD-Bromo cassettes in the 2.0 A˚ crystal structure of its
complex, such that the H3(1-10) segment containing the unmod-
ified K4 and K9me3mark targets the PHD finger of one cassette,
whereas the H3(11-20) segment containing the K14ac mark
targets the Bromo of another (Figure S4C). These data suggestell 147, 1511–1524, December 23, 2011 ª2011 Elsevier Inc. 1515
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Figure 3. TRIM33 Recognizes a Dual Histone Mark Typical of Poised Chromatin
(A) Representation of TRIM33 protein domains (top panel) and summary of H3 histone-binding specificity of the PHD-Bromo cassette based on the present
results (lower panel).
(B and C) Requirement of the PHD finger of TRIM33 for induction of Gsc andMixl1 by activin (B) or by nodal-like signals in the media (C). mESCs that were WT,
Trim33 depleted, or reconstituted with the indicated TRIM33 constructs were set for EB formation for 2.5 days and then incubated with activin or SB431542
for 2 hr. Total RNAwas analyzed by qRT-PCR using primers for the indicated genes. Error bars represent themean ±SD of quadruplicates and three independent
experiments.
(D, E, and G) Binding assays with biotinylated H3 histone peptides of the indicated lengths andmodifications. Peptides were coupled to avidin-agarose and used
as bait to pull down Flag-tagged TRIM33 generated in HEK293T cells (D andG) or a bacterially expressed, GST-tagged C-terminal fragment of TRIM33 (E). Bound
TRIM33 was detected by immunoblotting.
(F) ITC-based measurements indicate that TRIM33 PHD finger prefers to bind histone H3(1-15) containing unmodified lysine 4 and trimethylated lysine 9. KD
values are listed.
(H) ITC-based measurements of binding affinities of the TRIM33 PHD-Bromo cassette for H3(1-28) peptides containing combinations of modifications. KD values
are listed.
For additional information related to how TRIM33 recognizes poised chromatin, see Figure S3.that K14ac is too close to K9me3 for recognition by the PHD and
Bromos of the same TRIM33 molecule.
In addition to Trp stacking, a hydrogen bond between the side-
chain carbonyl of Gln895 and the amide proton of K9me3, aswell
as a stabilizing nonconventional carbon-oxygen hydrogen bond1516 Cell 147, 1511–1524, December 23, 2011 ª2011 Elsevier Inc.between the carbonyl oxygen of Gln894 and a methyl group of
K9me3, also contribute to the K9me3 recognition (Figure S4D).
In the highest-resolution structure of the Bromo, we observe
an array of water molecules that mediate Kac recognition within
the Bromo-binding pocket (Figures S4E andS4F). In the classical
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Figure 4. Structural Basis for TRIM33 PHD-Bromo Cassette Binding to Histone H3 Marks
(A) Superposition of the crystal structures of the PHD-Bromo cassettes of TRIM24 (cyan; PDB code: 3O33; 2.0 A˚) and TRIM33 (magenta; this study; 3.1 A˚) in the
free state. There is an additional a-helical segment extending from aB of Bromo in TRIM33 (dashed circle) relative to TRIM24.
(B) The 2.7 A˚ crystal structure of H3(1–22)K9me3-K14acK18ac peptide bound to a single TRIM33 PHD-Bromo cassette. The peptide is shown in a yellow stick
representation, together with labeled N terminus, and side chains of unmethylated K4, K9me3, and K18ac. The TRIM33 PHD-Bromo is shown in a ribbon
representation, with PHD in cyan and Bromo in brown colors.
(C) Detailed interactions between 1–9 segment of H3(1–22)K9me3-K14acK18ac peptide (in yellow) and the PHD finger (in cyan) of the TRIM33 PHD-Bromo
cassette in the complex. The side chains of residues 1–9 of the peptide are shown and labeled, together with PHD finger backbone and side-chain residues
involved in intermolecular hydrogen bond formation (dashed red lines). The two zinc ions of the PHD finger are indicated by silver balls.
(D) Recognition of R17-K18ac segment of H3(1–22)K9me3/K14ac/K18ac peptide (in yellow) by Bromo (in brown) of the TRIM33 PHD-Bromo cassette in the
complex. A hydrogen bond between Arg17 of the peptide and Glu981 of Bromo is shown by a dashed red line.
(E) ITC-basedmeasurements of binding affinities of threemutant forms of TRIM33 PHD-Bromo and their association with H3(1–28)K9me3K18ac histone peptide.
Figure S4 provides additional structural details of acetyllysine and K9me3-binding pockets.binding mode, as in the case of TRIM24, an invariant Asn in the
Bromo-binding pocket forms a stabilizing hydrogen bonding
with the acetyllysine, whereas in the TRIM33 complex, the corre-
sponding Asn1039 is 8.2 A˚ away from the oxygen of the acetyl-
lysine head group (Figure S4G).CWe used ITC to further test the cooperativity of unmodified K4,
trimethylated K9, and acetylated K18 on the same H3(1-28)
tail for binding to TRIM33 PHD-Bromo (Table S2). The binding
of TRIM33 PHD-Bromo to H3(1-28) (dissociation constant
[KD] = 0.46 mM) was enhanced 2.3-fold by either trimethylationell 147, 1511–1524, December 23, 2011 ª2011 Elsevier Inc. 1517
of K9 or acetylation of K18, and 3.5-fold by both marks
(Figure 3H). The mutants E981A, W889A, and C901W, which
would disrupt binding involving H3R17, H3K9me3, and H3K4,
respectively, showed reduced affinity for the H3 peptide
(Figures 3G and 4E). These data establish that unmodified K4,
trimethylated K9, and acetylated K18 are read in a
combinatorial manner by TRIM33 PHD-Bromo, thereby resulting
in the highest binding affinity.
Signal-Driven Binding of TRIM33 to H3K9me3 Domains
of the Gsc and Mixl1 Promoters
Our evidence linked the chromatin-binding function of TRIM33 to
the induction of Gsc and Mixl1 by nodal/activin signals. There-
fore, we investigated the interaction of TRIM33 and Smads
with the promoter regions of these two genes. Both promoters
contain an ARE immediately upstream of the start site. AREs
consist of a SBE and FoxH1 cognate sequences. FoxH1 binds
directly to Smad2/3 in the Smad2/3-Smad4 complex, and the
proteins cooperatively recognize the ARE (Chen et al., 1997;
Hart et al., 2005; Labbe´ et al., 1998).
Chromatin immunoprecipitation (ChIP) assays inmESCs using
antibodies against chromatin marks revealed a conserved
H3K9me3-rich region 2.3 kb upstream of the Gsc transcription
start site promoter, well separated from the ARE (Figure 5B;
summarized in Figure 5A). This region also contained
H3K14ac, H3K18ac, and H3K23ac, and low levels of H3K4me3
(Figure 5B, and refer to Figure S6), which was compatible with
TRIM33 binding. ChIP of mononucleosome preparations
showed the presence of both H3K9me3 and H3K18ac in the
same nucleosome at 2.3 kb in the Gsc promoter (Figures 5C
and S5A). This region also contained four SBEs between
2,327 and 2,281. Indeed, TRIM33 ChIP revealed a strong
activin-dependent binding to this region, but not to other regions
(Figure 5D). Smad2/3 ChIP showed activin-dependent binding of
Smad2/3 not only to the ARE at 0.4 kb but also to the K9me3
region at 2.3 kb (Figure 5D). Furthermore, depletion of
Smad2/3 prevented binding of TRIM33 to this region
(Figure 5D). Activin-dependent binding of Smad4 occurred only
at the ARE (refer to Figure 6A).
The region upstream of theMixl1 gene contains three SBEs at
0.5 kb in addition to an ARE at 0.2 kb. This region also
contains H3K9me3 and H3K18ac on the same nucleosome,
although these marks were also present in upstream regions
(Figures S5B and S5C; summarized in Figure 5E). Activin-
dependent binding of TRIM33 occurred near the Mixl1 ARE,
overlapping the region of Smad2/3 and Smad4 binding
(Figures 5E and 5F, and refer to Figure 6B). Depletion of
Smad2/3 inhibited the activin-dependent binding of TRIM33
(Figure S5D). Collectively, these results suggest that the
ligand-induced TRIM33-Smad2/3 and Smad4-Smad2/3
complexes bind, respectively, to H3K9me3-K18ac and ARE
sites in the Gsc and Mixl1 promoters (Figure 5G).
TRIM33 Is Essential for Smad2/3-Smad4 Binding
to AREs in Poised Promoters
Notably, Trim33 knockdown inhibited not only the binding of
Smad2/3 to the H3K9me3 region but also the binding of Smad2/3
and Smad4 to the ARE (Figure 6A). Similar results were obtained1518 Cell 147, 1511–1524, December 23, 2011 ª2011 Elsevier Inc.with the Mixl1 promoter (Figure 6B). Reconstitution of TRIM33
expression in the depleted cells with WT TRIM33 rescued the
binding of Smad4 to the ARE in both the Gsc and Mixl1
promoters, whereas reconstitution with TRIM33(Dphd) did not
(Figure 6C). These results suggest that the signal-driven binding
of TRIM33 and Smad2/3 to the H3K9me3 region enables binding
of Smad4 and Smad2/3 to the AREs (Figure 6D).
Comparison ofWT and Smad4 null ESCs revealed that Smad4
in turn enhanced the activin-induced binding of TRIM33 to its
sites (Figures 7A and S6A). Because Smad2/3-Smad4
complexes recruit p300 and other histone acetyltransferases to
the chromatin (Massague´ et al., 2005), we asked whether
activin stimulation induced acetylation of the Gsc and Mixl1
promoters. ChIP assays demonstrated a rapid, marked
increase in the level of H3K18ac in the TRIM33-binding regions
and throughout the promoters, in response to activin
(Figure 7B). The levels of H3K14ac and H3K23ac were also
increased by activin (Figure S6B). Furthermore, this increase in
histone H3 K18 acetylation was dependent on Smad4 and
TRIM33 (Figures 7B and S6B–S6G). Activin did not affect the
level of H3K9me3 throughout these regions of the Gsc and
Mixl1 promoters (Figures S6D and S6E). Thus, whereas the
binding of TRIM33-Smad2/3 to H3K9me3 is essential for binding
of Smad4 and Smad2/3 to the AREs, Smad4 reciprocally
enriches the TRIM33-binding region with H3K18ac mark and
enhances the binding of TRIM33 to this region.
TRIM33-Mediated Displacement of HP1
from H3K9me3-K18ac Dual Marks
The three HP1 family members (HP1a, b, and g) bind to H3K9me3
on pericentric and telomeric chromatin to enforce heterochroma-
tin organization. HP1 dimerization is thought to cause strapping
and condensation of H3K9me3-rich chromatin domains (Ruthen-
burg et al., 2007). HP1b and g are also found in developmentally
regulated, silent regions of the euchromatin in ESCs (Kwon and
Workman, 2008). Therefore, we investigated the ability of
TRIM33 to compete with HP1 for binding to histone H3 peptides
containing other modifications of interest (Figure 7C). A 3-fold
molar excess of TRIM33 was ineffective at competing with HP1g
for binding to peptide containing K9me3 as the sole modification
(Figure 7C). However, TRIM33 effectively outcompeted HP1g in
H3 peptides that additionally contained K18ac (Figure 7C).
These results are consistent with the higher affinity of TRIM33 for
H3K9me3-K18ac compared to H3K9me3 as the sole mark.
As a corollary to these results, we investigated the effect of ac-
tivin on the occupancy of TRIM33-binding sites by HP1 in ESCs.
HP1g ChIP assays revealed binding of the endogenous protein
to the TRIM33 target regions of the Gsc and Mixl1 promoters,
and this binding was inhibited by activin addition in a TRIM33-
dependent manner (Figure 7D). This was accompanied by an
increase in the level of Pol II binding to the initiator region
(Figure 7E), a hallmark of promoter activation (Young, 2011).
DISCUSSION
Nodal-Driven Smad Activation of Master Regulators
The Gsc and Mixl1 promoters in ESCs contain key features of
the poised state, including H3K9me3, which is often bound by
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Figure 5. Signal-Driven Binding of TRIM33 to H3K9me3 Domains of the Gsc and Mixl1 Promoters
(A) Scheme of the Gsc region spanning 3.3 kb upstream of the transcription start site, and sequence conservation plot between the human and mouse genomes
(VISTA graphs: conserved noncoding sequence is shown in pink). The positions of the ARE (Labbe´ et al., 1998), non-ARE SBEs, and H3K9me3-rich region
(present results) are shown.
(B) ChIP analysis of mESC EBs at day 2.5 using antibodies against the indicated histone H3 modified residues in the Gsc promoter region. Agarose protein A
(for rabbit antibodies) or G (for mouse antibodies) beads alone were used as negative controls.
(C) ChIP analysis of Gsc promoter regions was performed as indicated in (B) using mononucleosome preparations as template.
(D) WT or Smad2/3-depleted mESC EBs at day 2.5 were incubated with activin or SB 431542 for 2 hr; ChIP analysis of the Gsc promoter region was then
performed using anti-TRIM33 and Smad2/3 antibodies.
(E) Scheme of theMixl1 region spanning 4.5 kb upstream of the transcription start site, and sequence conservation plot between the human andmouse genomes
(VISTA graphs: conserved noncoding sequence is shown in pink). The positions of the ARE (Hart et al., 2005), non-ARE SBEs, and H3K9me3-rich region (present
results) are shown.
(F) mESC EBs at day 2.5 were incubated for 2 hr with the indicated additions. ChIP analysis of theMixl1 promoter region was performed using antibodies against
the indicated proteins.
(G) Schematic summary of signal-induced TRIM33-Smad2/3 and Smad4-Smad2/3 complexes binding to H3k9me3-K18ac and ARE sites, respectively, in the
Gsc and Mixl1 promoters.
Data in (B)–(D) and (F) were obtained by qRT-PCR of regions of interest in Gsc or Mixl1, and error bars represent the mean ± SD of quadruplicates and at least
three independent experiments. For additional information related to the Mixl1 promoter, see Figure S5.
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Figure 6. Smad2/3-Smad4 Binding to AREs
in Poised Promoters Required TRIM33
(A and B) WT or Trim33-depleted mESCs were set
to form EBs for 2.5 days and were then incubated
for 2 hr with the indicated additions. ChIP analysis
of the Gsc promoter (A) orMixl1 promoter (B) was
performed using antibodies against the indicated
proteins. Error bars represent the mean ± SD of
quadruplicates and at least three independent
experiments.
(C) mESCs that were WT, Trim33 depleted, or
reconstitutes with WT or truncated TRIM33
constructs were set to form EBs for 2.5 days. ChIP
analysis of the Gsc (0.4 kb) andMixl1 (combined
0.5 and 0.2 kb) promoters was done using
antibodies against Smad4. Error bars represent
the mean ± SD of quadruplicates and three inde-
pendent experiments.
(D) Schematic summary. Signal-driven binding of
TRIM33 and Smad2/3 to H3K9me3-rich regions of
Gsc and Mixl1 enables binding of Smad4 and
Smad2/3 to the AREs.the chromatin-compacting factor HP1g and a basal level of RNA
Pol II loaded on the start site. Our evidence suggests that nodal
TGF-b signals activate the expression of master mesendoderm
regulators through the following sequence of events (Figure 7F).
Nodal signaling triggers the formation of companion TRIM33-
Smad2/3 and Smad4-Smad2/3 complexes. The Smad4-
Smad2/3 complex (together with FoxH1) binds to ARE sites in
the Gsc and Mixl1 promoters, but for this to happen TRIM33-
Smad2/3 must act first. TRIM33 serves as a histone-binding
protein that recognizes the dual mark H3K9me3-K18ac through
the PHD-Bromo cassette. TRIM33 binds to nucleosomes con-
taining both marks in the Gsc andMixl1 promoters. The superior
affinity of TRIM33 for H3K9me3-K18ac displaces bound HP1g.
However, this requires Smad2/3 and nodal input, suggesting
that, in the complex, TRIM33 binds to H3K9me3-K18ac and
Smad2/3 to an adjacent CAGAC sequence. These events may
regionally remodel the chromatin to enable the access of
Smad4-Smad2/3 to AREs, which are located nearby in Mixl1 or
2 kb downstream in Gsc. The cooperation between the two
Smad complexes is reciprocal. The Smad4-Smad2/3 complex,
which is known to recruit histone acetyltransferases, increases
the regional content of H3K18ac and augments the binding of1520 Cell 147, 1511–1524, December 23, 2011 ª2011 Elsevier Inc.TRIM33-Smad2/3 to the promoters. As
a result of these events, nodal firmly
switches the master regulators Gsc and
Mixl1 from poised to activated state,
thereby committing primitive embryo
cells to mesendodermal fates (Figure 7F).
Other nodal/activin gene responses in
ESCs require Smad4, but not TRIM33.
Induction of the feedback regulator
Smad7 and the secreted protease inhib-
itor SerpinE1 are examples. Such
TRIM33-independent TGF-b responses
are the rule in human keratinocytes andbreast cancer cells. In differentiated cells the Smad pathway
primarily controls cell homeostasis through up- or downregula-
tion of active genes. Smad4-Smad2/3 access to such promoters
may solely depend on the availability of specific DNA-binding
Smad partners, as envisioned in the canonical Smad pathway
(Massague´ et al., 2005).
Structural Basis for TRIM33 Reading of Dual
Histone Marks
The PHD-Bromo cassette of TRIM33 is central to its role as
a nodal-driven switch of the poised chromatin state. This
cassette targets TRIM33 to K9me3 and K18ac marks together
with unmodified K4 on the same H3 tail. H3K9me3 stacks over
a single Trp ring of the TRIM33 PHD finger, in contrast to the
anticipated requirement of an aromatic cage for such cation-p
recognition (Taverna et al., 2007). The structure also explains
why methylation of K4 disrupts recognition by the PHD finger.
The TRIM33Bromo specifically recognizes the R17-K18acmotif,
thereby discriminating against other Kac residues in histone H3.
Furthermore, the TRIM33 Bromo forms an atypical binding
pocket, with the inserted Kac side chain stabilized by a water-
mediated hydrogen-bonding network. It is noteworthy that
whereas the TRIM24 Bromo recognizes the H3K23ac mark
(Tsai et al., 2010), the TRIM33 Bromo recognizes H3K18ac, as
dictated by the PHD-K9me3 anchoring interaction. TRIM24
binds estrogen receptor for activation of genes associated with
cell proliferation and tumorigenesis (Tsai et al., 2010),
establishing an interesting parallel with the cooperation of
TRIM33 with Smad2/3.
The present studies highlight the key contribution of spacer
length between the methylation and acetylation marks of histone
H3, as well as sequence context, to molecular recognition. A
recent report describing binding of TRIM33 to two acetylated
histone H3 marks (Agricola et al., 2011) missed the critical
interaction of the TRIM33 PHD-Bromo cassette with K9me3,
and postulated interactions of TRIM33 with the dual mark
K18ac-K23ac. Binding of a TRIM33 molecule to both acetylation
marks on the same histone H3 tail is not tenable based on the
present crystal structures. The combination of K4, K9me3, and
K18ac marks constitutes a unique recognition code, which
greatly enhances both the binding affinity and specificity of
TRIM33 for modified H3 tails. The combined binding specificity
for modified histone and DNA mediated by TRIM33 and
Smad2/3, respectively, ensures further selectivity in target
gene recognition.
TRIM33 in Differentiation Control
TRIM33 is a multifunctional protein, and the presently described
role of TRIM33 in the activation of master regulators involves
the Smad2/3 and histone-binding domains. Recently, TRIM33
was shown to mediate transcription elongation of erythroid
differentiation genes in hematopoietic progenitors, and this
effect involves TRIM33 binding to the hematopoietic transcrip-
tion factor SCL and the elongation factors p-TEFb and FACT
(Bai et al., 2010). These two roles of TRIM33—providing Smad
with access to poised differentiation genes, and promoting
transcription elongation of differentiation genes—could rep-
resent alternative modes of transcriptional control or coupled
events in a common process of gene regulation.
TRIM33 was proposed to function as a general inhibitor of
TGF-b and BMP pathways because it can mediate polyubiqui-
tylation and degradation of Smad4 (Dupont et al., 2005) or
inhibitory Smad4 monoubiquitylation (Agricola et al., 2011).
However, our evidence reveals an essential cooperation
between TRIM33 and Smad4 in the transcriptional control of
embryonic cell differentiation, and rules out TRIM33 as
a general inhibitor of Smad4. Trim33 and Smad4 conditional
KO models of mouse pancreatic cancer provide further
evidence for functional convergence of TRIM33 and Smad4
(Bardeesy et al., 2006; Vincent et al., 2009). TRIM33-mediated
ubiquitylation could represent a built-in negative feedback
activity. As precedent, the Pol II kinases CDK8 and CDK9 phos-
phorylate Smads1–3 for full activation, but in the process prime
Smads for ubiquitylation and degradation (Alarco´n et al., 2009;
Arago´n et al., 2011).
Trim33 null mouse embryos fail to form primitive streak and
mesoderm, but paradoxically, these embryos show a gain in
certain nodal/Smad4 response markers (Morsut et al., 2010).
Analysis of the Trim33 mutant phenotype is complicated by the
involvement of TRIM33 in the regulation of Lefty-1 by nodal.CLefty-1 is negative feedback factor that prevents nodal from
binding to its receptors and restricts nodal signaling (Shen,
2007). In the absence of TRIM33, a defective Lefty-1 feedback
loop would enhance nodal signaling through the remain-
ing Smad4 branch, suggesting an explanation for the paradox-
ical gain in Smad4 signaling markers in Trim33 null mouse
embryos.
Conclusions
We propose a mechanism for the activation of master regulators
in which nodal signaling drives the generation of two separate
transcriptional complexes: one that targets the H3K9me3 mark
of poised chromatin, and the other that targets response
elements in the samepromoter. These insights reveal a biochem-
ical basis for the poised state of master regulator genes.
H3K9me3 provides a binding site for HP1 factors that impose
gene repression, but at the same time, H3K9me3 provides an
entry point for TRIM33 to displace HP1 and allow binding of
signal-driven Smads for gene expression. Through this mecha-
nism, nodal TGF-b signals turn a repressive chromatin mark
into a platform for activation of master regulators of mesendo-
dermal differentiation. Relatedmechanisms could operate under
the control of other developmental signals that must bypass
repressive chromatin marks in order to control cell fate.
EXPERIMENTAL PROCEDURES
Cell Lines and Differentiation Assays
mESCs E14Tg2a.IV were maintained in feeder-layer free LIF-supplemented
medium (Keller, 1995). Stable Trim33 knockdown in mESCs cells was done
using LKO1 lentiviral constructs expressing shRNA against mouse Trim33
(Sigma-Aldrich; Clone ID: TRCN0000039531). We maintained Trim33 null
ESCs in C57Bl/6J background on mouse embryonic fibroblasts (MEFs;
Global Stem) with LIF-supplemented medium. Lentiviral vector infections
(Stewart et al., 2003) and plasmid transfections (Sapkota et al., 2007) were
performed as previously described. mESCs were maintained on gelatin-
coated plates. EB formation and differentiation were carried out as described
by the supplier (ATCC). Ectoderm differentiation assays were carried out as
described previously (Ying et al., 2003). Prior to total RNA extraction, cells
were treated with activin (50 ng/ml; R&D Systems) or SB431542 (10 mM;
Tocris). hESCs (WA-09; passage 35–45) were cultured on MEFs. The
medium was Dulbecco’s modified Eagle’s medium (DMEM)/F12 (GIBCO),
supplemented with 20% KnockOut Serum Replacement (GIBCO), 0.1 mM
b-mercaptoethanol, and 6 ng/ml of FGF-2. Cells were passaged with 6 U/ml
of dispase in hESC media, washed, and replated at a dilution of 1:3–1:5. For
mesodermal cell differentiation, hESCs were plated on Matrigel and cultured
in RPMI-B27 medium (Invitrogen). Recombinant human activin (100 ng/ml;
PeproTech) was supplemented for 24 hr, and 10 ng/ml human recombinant
BMP4 (R&D Systems) was added for 5 days thereafter as described previously
(Laflamme et al., 2007). HaCaT keratinocytes, HEK293T human embryonic
kidney cells, and MDA-MB-231 cells were cultured in DMEM supplemented
with 10% FBS.
Crystallization and Structure Determination
Details of crystallization conditions, data collection, and refinement are
provided under Extended Experimental Procedures. In brief all crystals were
grown at 20C by the hanging-drop method. Data sets for crystals of
TRIM33 PHD-Bromo in the free state and its complexes were collected at
synchrotron beamlines with the structures of TRIM33 PHD-Bromo cassette
in both the free state and with bound peptides solved by molecular replace-
ment using the published structure of the free form of TRIM24 (Protein Data
Bank [PDB]: 3O33) as the search model. The initial models were rebuilt in
COOT and further refined in PHENIX.ell 147, 1511–1524, December 23, 2011 ª2011 Elsevier Inc. 1521
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Figure 7. TRIM33 and SMAD Cooperation in Activation of Master Regulators
(A) mESCs that were WT, Smad2/3 depleted, or Smad4 null were set to form EBs for 2.5 days, then treated for 2 hr with activin or SB431542. ChIP analysis of the
Gsc promoter was done using antibodies against TRIM33. Error bars represent the mean ± SD of quadruplicates and three independent experiments.
(B) mESCs that were WT or Smad4 null were treated as in (A), and ChIP analysis of the Gsc and Mixl1 promoters was done using antibodies against H3K18ac.
Error bars represent the mean ± SD of quadruplicates and two independent experiments.
(C) TRIM33 competeswith HP1g for binding to H3K9me-K18ac. Biotinylated histone H3 peptides with the indicatedmodificationswere used in pull-down binding
assays with a fixed amount of Flag-tagged HP1g protein and an increasing amount of Flag-tagged TRIM33. Bead-bound proteins were analyzed by immuno-
blotting.
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ChIP
For ChIP, mESC EBs at 2.5 days were incubated with human recombinant
activin (50 ng/ml; R&D Systems) for 1 hr or SB431542 (10 mM; Tocris) for
2 hr. Cells were then cross-linked with 1% formaldehyde at 37C for 10 min
and quenched with 0.125 M glycine for 5 min at room temperature. ChIP
was performed using a ChIP assay kit (Millipore) as described in the manufac-
turer’s protocol. Immunoprecipitated DNA was analyzed by absolute
qRT-PCR, and the amplification product was expressed as percentage of
the input for each condition. For mononucleosome ChIP, cell lysates were di-
gested with titrations of micrococcal nuclease (Sigma-Aldrich; N5386), and
mononucleosome yield was verified by agarose gel electrophoresis. PCR
primer pairs used to amplify the unrelated control or promoter regions of
indicated genes are indicated in the Extended Experimental Procedures.ACCESSION NUMBERS
The X-ray coordinates of TRIM33 PHD-Bromo cassette in the free states and
when bound to H3(1–20)K9me3-K14ac, H3(1–22)K9me3-K14acK18ac, and
H3(1–28)K9me3-K14acK18acK23ac histone peptides have been deposited
in the PDB with the accession numbers of 3U5M, 3U5N, 3U5O, and 3U5P,
respectively.
Themicroarray gene expression dataset for ESCs has been deposited under
GEO accession number GSE32903.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and three tables and can be found with this article online at doi:10.
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experiments.
(E) Activin increases RNA Pol II binding to the Gsc and Mixl1 promoters, but not
antibodies against RNA Pol II and qRT-PCR primers amplifying the 0.1 kb regio
quadruplicates and two independent experiments.
(F) Schematic summary of signal-driven Smad activation of master regulators in E
including the H3K9me3 mark of quiescent chromatin and the chromatin-compa
cooperate to promote switching of the master regulators Gsc and Mixl1 from p
embryo cells to mesendodermal fate. See Discussion for more details.
Figure S6 provides additional information on the Smad4-dependent enhanceme
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